Abstract
A new series of 1,2-diazaindene-5-amine derivatives was rationally designed, synthesized, and evaluated against lung cancer cell line to analyse their cytotoxic potential. A series of 30 Indazole molecules (Y1-Y30) were designed using VEGFR-2 kinase (PDB ID: 4AG8). Substituted benzaldehydes were treated with hydrazine hydrate to afford 5-nitro indazole which was subsequently reduced to 5-amino indazole and subjected to amide coupling using acid derivatives to obtain substituted 1,2-diazaindene-5-amine derivatives. Out of 30 indazole derivatives, 10 compounds were found to show significant interactions with VEGFR-2. Binding energies of Y3, Y16, and Y29 were observed in the range of -7.237-7.897 Kcal/Mol. MD simulation studies on the compounds Y3, Y16, and Y29 confirmed stable conformational behaviour of the compounds and protein. Cytotoxicity was evaluated using an MTT assay on A549 lung cancer cells. In-vitro cytotoxicity studies reveal that Y29 and Y16 were the most viable lead compounds, exhibiting strong cytotoxicity in A549 cell lines with IC50 of 26.85±0.92 μg and 31.66±0.98 μg, respectively. Compounds Y29 and Y16 were found to be the most active cytotoxic compounds against the lung A549 cell lines, which would be promising future candidates for potential lung cancer research.